The Dominantly Inherited Alzheimer Network (DIAN) is an international research partnership dedicated to better understanding and treating FAD. It has established trials of treatments aiming to slow down or prevent the symptoms of FAD. The DIAN-TU trial hopes to determine if these medications can prevent, delay, or possibly even reverse Alzheimer’s disease changes in the brain. Some individuals from FAD families who are currently participating in research at the Dementia Research Centre, are taking part in these treatment trials. Participants are not required to know or learn their personal genetic mutation status in order to participate in these trials.

As new trials become available, eligible individuals from FAD families who are currently participating in research at the Dementia Research Centre, University College London (UCL) will be informed.

Family members who are not involved in research at the moment but who would like to find out about opportunities to participate in trials in the future can register their interest here or visit:
www.dianexpandedregistry.org.  

More information about the DIAN treatment trials can be found here.